Direxion Daily S&P Biotec... (LABU)
AMEX: LABU
· Real-Time Price · USD
97.57
3.96 (4.23%)
At close: Oct 01, 2025, 10:56 AM
4.23% (1D)
| Bid | 97.63 |
| Market Cap | 683.75M |
| AUM | 714.06M |
| NAV | 87.89 |
| EPS (ttm) | n/a |
| PE Ratio (ttm) | n/a |
| Shares Out | 7.01M |
| Inception Date | May 28, 2015 |
| Ask | 97.77 |
| Volume | 586,871 |
| Open | 93.20 |
| Previous Close | 93.61 |
| Day's Range | 93.20 - 98.49 |
| 52-Week Range | 32.55 - 152.58 |
| Holdings | 156 |
| Expense Ratio | 0.93% |
About LABU
The fund invests at least 80% of its net assets (plus borrowing for investment purposes) in financial instruments and securities of the index, exchange-traded funds ("ETFs") that track the index and other financial instruments that provide daily leveraged exposure to the index or ETFs that track the index. The index is designed to measure the performance of the biotechnology sub-industry based on the Global Industry Classification Standards ("GICS"). The fund is non-diversified.
Asset Class Equity
Ticker Symbol LABU
Inception Date May 28, 2015
Provider Direxion
Website Fund Home Page
Exchange AMEX
Top 10 Holdings 3.42% of assets
| Name | Symbol | Weight |
|---|---|---|
| Crispr Therapeutics ... | CRSP | 0.40% |
| Exelixis, Inc. | EXEL | 0.35% |
| United Therapeutics ... | UTHR | 0.35% |
| Abbvie Inc. | ABBV | 0.34% |
| Moderna, Inc. | MRNA | 0.34% |
| Madrigal Pharmaceuti... | MDGL | 0.33% |
| Revolution Medicines... | RVMD | 0.33% |
| Vertex Pharmaceutica... | VRTX | 0.33% |
| Regeneron Pharmaceut... | REGN | 0.33% |
| Ionis Pharmaceutical... | IONS | 0.32% |
Dividends Dividend Yield 0.5%
| Ex-Dividend | Amount | Payment Date |
|---|---|---|
| Sep 23, 2025 | $0.1027 | Sep 30, 2025 |
| Jun 24, 2025 | $0.2190 | Jul 1, 2025 |
| Mar 25, 2025 | $0.1071 | Apr 1, 2025 |
| Jun 25, 2024 | $0.1502 | Jul 2, 2024 |
| Mar 19, 2024 | $0.1606 | Mar 26, 2024 |
